BRIM Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5.49	0.33	0.09	0.53	0.36
Revenue Growth (YoY)	1548.65%	270.00%	-82.89%	46.11%	-99.60%
Cost of Revenue	4.24	0.31	-	-	-
Gross Profit	1.25	0.02	0.09	0.53	0.36
Selling, General & Admin	123.68	106.31	112.33	72.96	44.97
Research & Development	330.54	238.5	581.88	145.89	48.6
Operating Expenses	454.22	344.81	694.22	218.85	93.58
Operating Income	-452.97	-344.79	-694.13	-218.33	-93.22
Interest Expense	-0.5	-0.09	-0.15	-0.08	-0.11
Interest & Investment Income	31.76	32.9	21.8	0.83	0.5
Earnings From Equity Investments	-13.47	-27.03	-24.59	-62.62	-47.94
Currency Exchange Gain (Loss)	-15.66	23.53	9.03	5.9	-1.76
Other Non Operating Income (Expenses)	-0.07	-	0	0.02	4.21
EBT Excluding Unusual Items	-450.92	-315.47	-688.04	-274.28	-138.32
Gain (Loss) on Sale of Assets	-	-	0.01	-	32.87
Other Unusual Items	0.01	-	-	-	-
Pretax Income	-450.91	-315.47	-688.02	-274.28	-105.45
Earnings From Continuing Operations	-450.91	-315.47	-688.02	-274.28	-105.45
Minority Interest in Earnings	14.46	-	-	-	-
Net Income	-436.45	-315.47	-688.02	-274.28	-105.45
Net Income to Common	-436.45	-315.47	-688.02	-274.28	-105.45
Shares Outstanding (Basic)	132	117	101	71	59
Shares Outstanding (Diluted)	132	117	101	71	59
Shares Change (YoY)	12.74%	16.02%	41.02%	20.23%	0.72%
EPS (Basic)	-3.32	-2.70	-6.84	-3.85	-1.78
EPS (Diluted)	-3.32	-2.70	-6.84	-3.85	-1.78
Free Cash Flow	-329.97	-282.14	-599.15	-172.98	-113.35
Free Cash Flow Per Share	-2.51	-2.42	-5.96	-2.43	-1.91
Gross Margin	22.77%	6.61%	100.00%	100.00%	100.00%
Operating Margin	-8250.89%	-103539.04%	-771250.00%	-41506.84%	-25893.06%
Profit Margin	-7949.94%	-94735.74%	-764468.89%	-52143.92%	-29291.39%
Free Cash Flow Margin	-6010.38%	-84726.73%	-665723.33%	-32885.74%	-31485.83%
EBITDA	-417.6	-340.5	-693.12	-218.02	-93.01
D&A For EBITDA	35.37	4.29	1.01	0.31	0.2
EBIT	-452.97	-344.79	-694.13	-218.33	-93.22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.